Impact BioMedical Inc.
IBO
$0.6439
$0.03195.21%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 32.81% | -13.87% | |||
| Depreciation & Amortization | 1.77% | 1.43% | |||
| Other Operating Expenses | -4.35% | 1.77% | |||
| Total Operating Expenses | 14.85% | 15.43% | |||
| Operating Income | -14.16% | -15.43% | |||
| Income Before Tax | -1,023.00% | 95.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1,023.00% | 95.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -45.45% | -56.00% | |||
| Net Income | -1,032.28% | 95.33% | |||
| EBIT | -14.16% | -15.43% | |||
| EBITDA | -14.07% | -15.58% | |||
| EPS Basic | -1,021.24% | 95.54% | |||
| Normalized Basic EPS | -1,026.49% | 29.41% | |||
| EPS Diluted | -972.73% | 95.33% | |||
| Normalized Diluted EPS | -1,026.49% | 29.41% | |||
| Average Basic Shares Outstanding | 1.02% | 4.81% | |||
| Average Diluted Shares Outstanding | 1.02% | 4.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||